GLP-1 Medications and Kidney Stones: What You Need to Know

If you're taking a GLP-1 medication like semaglutide or tirzepatide for weight loss or diabetes management, you might be wondering about potential side effects beyond the commonly discussed nausea and digestive issues. One question that comes up: can these medications increase your risk of kidney stones?

The short answer is that while GLP-1 medications don't directly cause kidney stones, certain side effects can create conditions that increase risk in some people. Let's break down what you need to know to protect your kidney health while benefiting from GLP-1 therapy.

Understanding the GLP-1 and Kidney Stone Connection

GLP-1 receptor agonists work by mimicking a natural hormone that regulates blood sugar and appetite. These medications have been extensively studied for safety, and kidney stones aren't listed as a direct side effect.

However, the way GLP-1 medications affect your body can indirectly influence kidney stone risk through several mechanisms.

Dehydration: The Primary Concern

The most significant connection between GLP-1 medications and kidney stones relates to hydration status. These medications slow gastric emptying and can reduce your appetite, which often means you're drinking less without realizing it.

When you're not drinking enough water, your urine becomes more concentrated. This concentration allows minerals like calcium and oxalate to crystallize more easily, forming stones.

Many people starting GLP-1 therapy also experience nausea, vomiting, or diarrhea, especially in the first few weeks. These gastrointestinal side effects can lead to fluid loss, further increasing dehydration risk.

Rapid Weight Loss Effects

GLP-1 medications are highly effective for weight loss, with many people losing significant weight relatively quickly. While this is often the desired outcome, rapid weight loss can temporarily increase kidney stone risk.

When your body breaks down fat stores quickly, it releases substances that can alter your urine chemistry. This metabolic shift can increase uric acid levels and change the pH of your urine, both of which may contribute to stone formation.

Who's at Higher Risk?

Not everyone taking GLP-1 medications faces the same kidney stone risk. Certain factors make some people more vulnerable:

• Previous history of kidney stones: If you've had stones before, you're more likely to develop them again
• Family history: Kidney stones often run in families
• Chronic dehydration: Living in hot climates or not drinking adequate fluids baseline
• High-protein, low-carb diets: These eating patterns, sometimes combined with GLP-1 therapy, can increase stone risk
• Certain medical conditions: Including gout, inflammatory bowel disease, or metabolic syndrome

Gender Differences in Kidney Stone Risk

Historically, men have been more likely to develop kidney stones than women, with about a 2:1 ratio. However, this gap has been narrowing in recent years.

Women face unique considerations when it comes to kidney stones and GLP-1 therapy. Hormonal changes during menopause can affect calcium metabolism and bone health, potentially influencing stone risk. Additionally, women are more prone to urinary tract infections, which can sometimes be confused with or contribute to stone formation.

That said, the dehydration risk from GLP-1 medications affects all genders equally, making hydration important for everyone on these therapies.

Recognizing Kidney Stone Symptoms

Knowing the warning signs of kidney stones helps you seek timely medical attention. Symptoms can include:

• Severe pain in your side, back, or below your ribs
• Pain that radiates to your lower abdomen or groin
• Pain that comes in waves and fluctuates in intensity
• Pink, red, or brown urine
• Cloudy or foul-smelling urine
• Nausea and vomiting
• Frequent need to urinate or burning during urination

Because some of these symptoms overlap with common GLP-1 side effects (like nausea), it's important to pay attention to new or worsening symptoms, especially severe pain or blood in your urine.

Prevention Strategies While Taking GLP-1 Medications

The good news is that kidney stones are largely preventable with the right approach. Here's how to protect yourself while benefiting from GLP-1 therapy:

Prioritize Hydration

This is your most important defense against kidney stones. Aim for at least 8-10 glasses of water daily, and more if you're active or in warm weather.

A good rule of thumb: your urine should be pale yellow or clear. If it's dark or concentrated-looking, you need more fluids.

Set reminders on your phone if needed, since GLP-1 medications can reduce your natural thirst signals.

Monitor Your Diet

While you don't need to follow a restrictive diet, certain adjustments can help:

• Limit sodium intake, which increases calcium in your urine
• Don't overdo protein, especially animal protein
• Get adequate calcium from food sources (don't restrict it, as this can actually increase stone risk)
• Limit oxalate-rich foods if you're prone to calcium oxalate stones (spinach, nuts, chocolate, tea)
• Reduce sugary drinks and excessive caffeine

Stay Active and Lose Weight Gradually

While GLP-1 medications often lead to significant weight loss, working with your healthcare provider to ensure a steady, sustainable pace can reduce metabolic stress on your kidneys.

Communicate With Your Healthcare Provider

Be upfront about any history of kidney stones before starting GLP-1 therapy. Your doctor may want to monitor your kidney function or recommend additional preventive measures.

If you develop any symptoms that concern you while on treatment, don't hesitate to reach out.

The Bottom Line on GLP-1s and Kidney Stones

While GLP-1 medications like semaglutide and tirzepatide don't directly cause kidney stones, staying mindful of hydration and certain risk factors is important for everyone taking these medications.

For most people, the significant health benefits of GLP-1 therapy—including weight loss, improved blood sugar control, and reduced cardiovascular risk—far outweigh the manageable risk of kidney stones. With proper hydration and awareness, you can safely pursue your health goals while protecting your kidneys.

From the Ozari Care Team

Stay ahead of dehydration by drinking a full glass of water first thing in the morning and another glass before each dose of your GLP-1 medication. If you're experiencing persistent nausea that's making it hard to stay hydrated, talk to your care team about anti-nausea strategies or dose adjustments. Prevention is always easier than treatment when it comes to kidney stones.

At Ozari Health we offer compounded Semaglutide and Tirzepatide as low as $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 25, 2026